We are live on ! Find out more
ETON icon

Eton Pharmaceutcials

86 hedge funds and large institutions have $190M invested in Eton Pharmaceutcials in 2025 Q1 according to their latest regulatory filings, with 26 funds opening new positions, 29 increasing their positions, 22 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

136% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 11

87% more call options, than puts

Call options by funds: $891K | Put options by funds: $476K

32% more repeat investments, than reductions

Existing positions increased: 29 | Existing positions reduced: 22

21% more funds holding

Funds holding: 7186 (+15)

3.34% more ownership

Funds ownership: 51.15%54.49% (+3.3%)

5% more capital invested

Capital invested by funds: $182M → $190M (+$8.19M)

50% less funds holding in top 10

Funds holding in top 10: 21 (-1)

Holders
86
Holders Change
+15
Holders Change %
+21.13%
% of All Funds
1.15%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.01%
New
26
Increased
29
Reduced
22
Closed
11
Calls
$891K
Puts
$476K
Net Calls
+$415K
Net Calls Change
-$3.46M

ETON Hedge Fund Activity: Q1 2025 in Review

86 of the 7,472 institutional investors tracked by Wall St. Rank reported a position in Eton Pharmaceutcials (ETON) for Q1 2025, worth a combined $190M — up 4.5% from $182M a quarter earlier.

Buyers outnumbered sellers: 26 funds opened new ETON positions and 11 closed out — a net gain of 15 holders — while 29 added to existing stakes and 22 trimmed.

The largest buyer was Stifel Financial, opening a new position worth an estimated $4.83M. The largest seller was Mink Brook Asset Management, cutting an estimated $4.75M.

  • 86 institutional investors held Eton Pharmaceutcials (ETON) as of Q1 2025, up from 71 in Q4 2024.
  • Funds reported $190M of Eton Pharmaceutcials stock for Q1 2025, up 4.5% quarter-over-quarter.
  • 26 funds opened new Eton Pharmaceutcials positions in Q1 2025 and 11 closed out, a net change of +15 holders.
  • The largest Eton Pharmaceutcials buyer in Q1 2025 was Stifel Financial, an estimated $4.83M added.
  • The largest Eton Pharmaceutcials seller in Q1 2025 was Mink Brook Asset Management, an estimated $4.75M sold.

Based on aggregated 13F filings for Q1 2025.